Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 22.95B | 19.52B | 12.98B | -21.64B | 46.50B | 40.65B |
Gross Profit | 22.95B | 19.52B | 2.37B | 14.29B | 46.50B | 40.65B |
EBITDA | -5.59B | 635.00M | -204.00M | 1.00B | 2.58B | 169.00M |
Net Income | 1.30B | 688.00M | -179.00M | -570.00M | 1.98B | 45.00M |
Balance Sheet | ||||||
Total Assets | 310.63B | 327.39B | 301.58B | 401.79B | 468.25B | 443.81B |
Cash, Cash Equivalents and Short-Term Investments | 53.68B | 58.18B | 4.07B | 64.31B | 108.25B | 109.00B |
Total Debt | 4.27B | 5.00B | 4.92B | 6.67B | 12.23B | 11.07B |
Total Liabilities | 301.25B | 318.08B | 292.03B | 387.60B | 441.88B | 419.15B |
Stockholders Equity | 9.26B | 9.19B | 7.55B | 10.76B | 26.18B | 24.59B |
Cash Flow | ||||||
Free Cash Flow | -116.00M | 711.00M | 799.00M | 2.75B | -1.91B | -2.97B |
Operating Cash Flow | -61.00M | 762.00M | 864.00M | 2.85B | -1.80B | -2.85B |
Investing Cash Flow | 447.00M | 300.00M | -2.00B | 616.00M | -54.00M | -139.00M |
Financing Cash Flow | -1.48B | -1.75B | -3.24B | -1.83B | 300.00M | -778.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | $33.43B | 9.25 | 17.09% | ― | 23.79% | -32.09% | |
74 Outperform | $34.86B | 11.24 | 19.55% | 1.68% | 7.67% | 15.99% | |
69 Neutral | $12.13B | 8.49 | 14.42% | 5.74% | -6.19% | ― | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
67 Neutral | $45.02B | 15.06 | 7.61% | 2.21% | -33.87% | -5.72% | |
67 Neutral | $18.02B | 16.29 | 10.16% | 3.85% | -3.34% | -3.32% | |
57 Neutral | $14.58B | 39.25 | 34.30% | 2.16% | 5.05% | -47.26% |
On September 2, 2025, Aegon Ltd. announced its intention to sell approximately 12.5 million ordinary shares in ASR Nederland N.V., representing about 6% of a.s.r.’s share capital. This sale will be conducted through an accelerated bookbuild offering to qualified institutional investors. Following the sale, Aegon’s stake in a.s.r. will decrease from 29.96% to around 24%, although Aegon will remain the largest shareholder and continue to support a.s.r.’s strategy. The proceeds from the sale will be managed under Aegon’s capital management framework, with a commitment to reduce its Cash Capital at Holding to around EUR 1.0 billion by the end of 2026.
On August 25, 2025, Aegon announced an increase in its share buyback program from EUR 200 million to EUR 400 million, which began on July 1, 2025. The increase, first announced on August 21, 2025, involves participation from its largest shareholder, Vereniging Aegon, and is expected to be completed by December 15, 2025. The buyback is conducted under the EU’s Market Abuse Regulation and aims to cancel the repurchased shares, potentially impacting Aegon’s market positioning and shareholder value.
Aegon Ltd. reported strong financial results for the first half of 2025, with a net profit of EUR 606 million compared to a net loss in the same period last year. The operating result increased by 19%, driven by business growth and improved performance in the United States. The company announced an increase in its share buyback program and a higher interim dividend. Aegon is also reviewing the potential relocation of its legal domicile and head office to the United States to align its corporate structure with its primary market, which could simplify its operations and regulatory framework.
Aegon Ltd. released its interim financial information for the first half of 2025, reporting a net profit of EUR 606 million, a significant turnaround from a net loss of EUR 65 million in the same period of 2024. The operating result increased by 19% to EUR 845 million, driven by business growth and improved experience variance in the US, indicating a positive impact on the company’s financial health and market positioning.